Latest Research Hot Spots of Atopic Dermatitis Management Using Janus Kinase Inhibitor: A Bibliometric Analysis and Visualized Review
Houriah Nukaly, Deemah S AlHuraish, Basel H Bakhamees, Haya A AlHemli, Mai S Alsaadoon, Renad K Alhejji, Ghaid Alotaibi, Shikhah A Alomran, Zeinah AlHalees · 2025
Read Latest Research Hot Spots of Atopic Dermatitis Management Using Janus Kinase Inhibitor: A Bibliometric Analysis and Visualized Review by Houriah Nukaly, Deemah S AlHuraish, Basel H Bakhamees, Haya A AlHemli, Mai S Alsaadoon, Renad K Alhejji, Ghaid Alotaibi, Shikhah A Alomran, Zeinah AlHalees (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12710625.txt.
Description
Houriah Nukaly and eight co-authors published a bibliometric review in 2025 mapping research on a drug class for severe eczema. Janus kinase inhibitors changed the options for moderate to severe disease, and papers multiplied fast. Rather than testing a treatment, the team charted the field itself: who publishes, where, and on what hot topics.
They gathered 776 papers from a major citation database covering twenty fourteen to twenty twenty-four. The United States led output, followed by Germany, Japan, and China. Two American centers published most, while a Japanese university drew the most citations per paper. Two senior researchers topped the author list. The maps show newcomers where the active fronts and the strong partnerships sit.
Catalog record
| CREATOR | Houriah Nukaly, Deemah S AlHuraish, Basel H Bakhamees, Haya A AlHemli, Mai S Alsaadoon, Renad K Alhejji, Ghaid Alotaibi, Shikhah A Alomran, Zeinah AlHalees |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |